Skip to main content

Advertisement

Log in

Outcome of Cyclosporine Monotherapy in Patients of Aplastic Anemia: Experience of a Tertiary Care Hospital in Eastern India

  • Correspondence
  • Published:
Indian Journal of Hematology and Blood Transfusion Aims and scope Submit manuscript

Abstract

Introduction

Immune suppression is a crucial pillar for treatment of aplastic anemia. Cyclosporine monotherapy is an easily available, affordable therapeutic option with good safety profile.

Methods and Materials

This prospective study was conducted over a period of 2 years from June 2012 to July 2014. The diagnosis and response to treatment of aplastic anemia was established as per published criteria. Follow up was done at 3 and 6 months in order to assess the response.

Results

57 patients of acquired aplastic anemia with median age of 37 years (6 to 81 years) were included in the study. 35 (62 %) cases were severe aplastic anemai, 16 (28 %) non severe aplastic anemia and 6 (10 %) were very severe aplastic anemia. At 3 months overall response rate (OR) was 7 (14 %) and at 6 months the OR rate of 11 (19.6 %) was achieved. Transiently raised creatinine, liver function abnormality and gum hypertrophy were the main side effects observed in this cohort.

Conclusion

Oral cyclosporine monotherapy at dose of 5 mg/kg/day is a relatively safe treatment option for resource poor patients with aplastic anemia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

References

  1. Young NS, Maciejewski J (1997) The pathophysiology of acquired aplastic anemia. N Engl J Med 336:1365–1372

    Article  CAS  PubMed  Google Scholar 

  2. Gluckman E, Esperou-Bourdeau H, Baruchel A, Boogaerts M, Briere J, Donadio D et al (1992) Multicentre randomized study comparing cyclosporin A alone and ATG with prednisone for the treatment of aplastic anemia. Blood 79:2540–2546

    CAS  PubMed  Google Scholar 

  3. Camitta BM (2000) what is the definition of cure for aplastic anemia? Acta Haematol 103:16–18

    Article  CAS  PubMed  Google Scholar 

  4. Marsh J, Schrezenmeier H, Marin P et al (1999) Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party. Blood 93:2191–2195

    CAS  PubMed  Google Scholar 

  5. Camitta BM (1984) Pathogenesis and treatment of aplastic anemia. RhinsoKetseuki 25:459–469

    CAS  Google Scholar 

  6. Malhotra P, Gella V, Guru Murthy GS, Varma N, Varma S (2015) High incidence of aplastic anemia is linked with lower socioeconomic status of Indian population. J Public Health. doi:10.1093/pubmed/fdv027: First published online: March 8, 2015

  7. Dasgupta S, Mandal PK, Chakrabarti S (2015) Etiology of pancytopenia: an observation from a Referral Medical Institution of Eastern Region of India. J Lab Physicians 7:90–95

    Article  PubMed  PubMed Central  Google Scholar 

  8. Chakrabarti S, Goswami BK, Paul PC, Sarkar S, Mondal S, Das S (2013) Clinico haematological profile of aplastic anaemia in a rural medical college of Northern West Bengal. J Indian Med Assoc 111:670–673

    PubMed  Google Scholar 

  9. Tokuda M, Kurata N, Mizoguchi A, Inoh M, Seto K, Kinashi M, Takahara J (1994) Effect of low-dose cyclosporin A on systemic lupus erythematosus disease activity. Arthritis Rheum 37:551–558

    Article  CAS  PubMed  Google Scholar 

  10. Hami M, Mojahedi MJ, Naghibi M, Shakeri MT, Sharifipour F (2010) Cyclosporine trough levels and its side effects in kidney transplant recipients. Iran J Kidney Dis 4:153–157

    PubMed  Google Scholar 

Download references

Authors Contribution

Contributor

Concept

Study design

Data collection

Statistical analysis

Literature overview

Discussion

Fund generation

Prakas Kumar Mandal

Yes

Yes

Yes

Yes

Yes

Yes

Nil

Suvraneel Baul

Yes

Yes

Yes

Yes

Yes

Yes

Nil

Tuphan Kanti Dolai

Yes

Yes

Yes

Nil

Rajib De

Yes

Yes

Yes

Nil

Prantar Chakrabarti

Yes

Yes

Yes

Yes

Nil

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Prakas Kumar Mandal.

Ethics declarations

Conflict of interest

The authors have declared no competing interests.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mandal, P.K., Baul, S., Dolai, T.K. et al. Outcome of Cyclosporine Monotherapy in Patients of Aplastic Anemia: Experience of a Tertiary Care Hospital in Eastern India. Indian J Hematol Blood Transfus 33, 144–147 (2017). https://doi.org/10.1007/s12288-016-0706-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12288-016-0706-7

Keywords

Navigation